Skip to main content
Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Correction: Chemical Genomic-Based Pathway Analyses for Epidermal Growth Factor-Mediated Signaling in Migrating Cancer Cells

  • The PLOS ONE Staff
  • Article
  • Metrics
  • Comments
  • Media Coverage

There are errors in Figure 2. The top label indicating EGF treatments, positive or negative, are inverse. Please see the corrected Figure 2 here.

thumbnail
Figure 2. Effects of small molecule inhibitors on EGF-induced migration signaling in three cancer cell lines.

Heat maps depict the effects of small molecule inhibitors on EGF-induced signaling in A431 cells (top), EC109 cells (middle), and TT cells (bottom). Data were normalized by centering non-treat condition as 0, and scaling EGF-treated condition to 1. All cell lines were treated with EGF after pre-treatment with inhibitors for 15 min. After the indicated time, the cells were collected and subjected to western blotting. AMD; Actinomycin D, CHX; Cycloheximide, HMA; Herbimycin A. The concentration of chemical inhibitors are listed in Table S2. Original immunoblot images are shown in Figure S2.

https://doi.org/10.1371/journal.pone.0096776.g002

Reference

  1. 1. Magi S, Saeki Y, Kasamatsu M, Tashiro E, Imoto M (2014) Chemical Genomic-Based Pathway Analyses for Epidermal Growth Factor-Mediated Signaling in Migrating Cancer Cells. PLoS ONE 9(5): e96776